{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:16:05Z","timestamp":1777572965782,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T00:00:00Z","timestamp":1590364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"RBAC-QoL"},{"name":"BioMedica Nutraceuticals Pty Ltd"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.conctc.2020.100580","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T02:38:56Z","timestamp":1590719936000},"page":"100580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Rice bran arabinoxylan compound and quality of life of cancer patients (RBAC-QoL): Study protocol for a randomized pilot feasibility trial"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0534-3673","authenticated-orcid":false,"given":"Soo Liang","family":"Ooi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8510-5781","authenticated-orcid":false,"given":"Sok Cheon","family":"Pak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7238-3878","authenticated-orcid":false,"given":"Peter S.","family":"Micalos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7792-5744","authenticated-orcid":false,"given":"Emily","family":"Schupfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4807-8523","authenticated-orcid":false,"given":"Rob","family":"Zielinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Jeffries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garth","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry","family":"Golombick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9549-9921","authenticated-orcid":false,"given":"David","family":"McKinnon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.conctc.2020.100580_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1634\/theoncologist.7-2-120","article-title":"The cancer patient and quality of life","volume":"7","author":"Bottomley","year":"2002","journal-title":"Oncol."},{"key":"10.1016\/j.conctc.2020.100580_bib2","first-page":"167","article-title":"How and why systemic inflammation worsens quality of life in patients with advanced cancer","volume":"2","author":"McSorley","year":"2017","journal-title":"Expert Rev. Qual. Life Cancer Care"},{"key":"10.1016\/j.conctc.2020.100580_bib3","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1634\/theoncologist.2013-0120","article-title":"The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer","volume":"18","author":"Laird","year":"2013","journal-title":"Oncol."},{"key":"10.1016\/j.conctc.2020.100580_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.conctc.2020.100580_bib5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.conctc.2020.100580_bib6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ncb3015","article-title":"The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis","volume":"16","author":"McAllister","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.conctc.2020.100580_bib7","first-page":"161","article-title":"Cytokines in the systemic inflammatory response syndrome: a review","volume":"2","author":"Jaffer","year":"2010","journal-title":"HSR Proc. Intensive Care Cardiovasc. Anesth."},{"key":"10.1016\/j.conctc.2020.100580_bib8","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1200\/JCO.2015.65.7742","article-title":"Quality of life in patients with advanced cancer: differential association with performance status and systemic inflammatory response","volume":"34","author":"Laird","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.conctc.2020.100580_bib9","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3389\/fimmu.2018.01195","article-title":"Neuroimmunology of behavioral comorbidities associated with cancer and cancer treatments","volume":"9","author":"Santos","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.conctc.2020.100580_bib10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/039463201102400412","article-title":"Activation of human monocyte-derived dendritic cells in vitro by the biological response modifier arabinoxylan rice bran (MGN-3\/Biobran)","volume":"24","author":"Ghoneum","year":"2011","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.conctc.2020.100580_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3835(03)00458-0","article-title":"Modified arabinoxylan rice bran (MGN-3\/Biobran) sensitizes human T cell leukemia cells to death receptor (CD95)-induced apoptosis","volume":"201","author":"Ghoneum","year":"2003","journal-title":"Canc. Lett."},{"key":"10.1016\/j.conctc.2020.100580_bib12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jcyt.2014.11.001","article-title":"Arabinoxylan rice bran (MGN-3\/Biobran) enhances natural killer cell-mediated cytotoxicity against neuroblastoma in vitro and in vivo","volume":"17","author":"P\u00e9rez-Mart\u00ednez","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.conctc.2020.100580_bib13","first-page":"1006","article-title":"From bench to bedside\u00a0: the growing use of arabinoxylan rice bran (MGN-3\/Biobran) in cancer immunotherapy","volume":"1","author":"Ghoneum","year":"2016","journal-title":"Austin Immunol."},{"key":"10.1016\/j.conctc.2020.100580_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.carbpol.2015.11.068","article-title":"Arabinoxylans, gut microbiota and immunity","volume":"139","author":"Mendis","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.conctc.2020.100580_bib15","series-title":"Intest. Microbiome Funct. Asp. Heal. Dis. Nestl\u00e9 Nutr Inst Work. Ser.","first-page":"45","article-title":"Gut-brain axis and behavior","author":"Martin","year":"2017"},{"key":"10.1016\/j.conctc.2020.100580_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1534735417735379","article-title":"Evidence-based review of BioBran\/MGN-3 arabinoxylan compound as a complementary therapy for conventional cancer treatment","volume":"17","author":"Ooi","year":"2018","journal-title":"Integr. Canc. Ther."},{"key":"10.1016\/j.conctc.2020.100580_bib17","first-page":"281","article-title":"One case of a patient with umbilical metastasis of recurrent cancer (Sister Mary Joseph's Nodule, SMJN) who has survived for a long time under immunomodulatory supplement therapy","volume":"14","author":"Kawai","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.conctc.2020.100580_bib18","first-page":"273","article-title":"A case where an immunomodulatory food was effective in conservative therapy for progressive terminal pancreatic cancer","volume":"14","author":"Kaketani","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.conctc.2020.100580_bib19","first-page":"289","article-title":"The clinical significance of modified arabinoxylan from rice bran (BioBran\/MGN-3) in immunotherapy for cancer","volume":"14","author":"Okamura","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.conctc.2020.100580_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00042728-200601000-00031","article-title":"Metastatic hemangiopericytoma of the skin treated with wide local excision and MGN-3","volume":"32","author":"Markus","year":"2006","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.conctc.2020.100580_bib21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.15761\/CCRR.1000176","article-title":"Can a synergistic activation of pattern recognition receptors by plant immunomodulators enhance the effect of oncologic therapy? Case report of a patient with uterus and ovary sarcoma","volume":"1","author":"Hajto","year":"2015","journal-title":"Clin. Case Rep. Rev."},{"key":"10.1016\/j.conctc.2020.100580_bib22","doi-asserted-by":"crossref","first-page":"456","DOI":"10.15761\/CCRR.1000244","article-title":"Can the EGFR inhibitors increase the immunomodulatory effects of standardized plant extracts (mistletoe lectin and arabonoxylan) with clinical benefit? Case report of a patient with lung adenocarcinoma","volume":"2","author":"Hajt\u00f3","year":"2016","journal-title":"Clin. Case Rep. Rev."},{"key":"10.1016\/j.conctc.2020.100580_bib23","first-page":"46","article-title":"A case of stage IV hepatocellular carcinoma treated by KM900, Biobran, and psychotherapy has presented significant good results","volume":"1","author":"Meshitsuka","year":"2013","journal-title":"Pers. Med. Universe (Japanese Ed. )"},{"key":"10.1016\/j.conctc.2020.100580_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11136-019-02286-7","article-title":"The enhancing effects of Biobran\/MGN-3, an arabinoxylan rice bran, on healthy old adults' health-related quality of life: a randomized, double-blind, placebo-controlled clinical trial","volume":"29","author":"Elsaid","year":"2020","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.conctc.2020.100580_bib25","first-page":"13","article-title":"\u201cBIOBRAN MGN-3\"; Effect of reducing side effects of chemotherapy in breast cancer patients","volume":"20","author":"Masood","year":"2013","journal-title":"Prof. Med. J."},{"key":"10.1016\/j.conctc.2020.100580_bib26","first-page":"267","article-title":"Life prolongation and QOL improvement effect of modified arabinoxylan from rice bran (BioBran\/MGN-3) for progressive cancer","volume":"14","author":"Takahara","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.conctc.2020.100580_bib27","first-page":"2","article-title":"Improvement of quality of life in tumor patients after an immunomodulatory treatment with standardized mistletoe lectin and arabinoxylan plant extracts","author":"Hajt\u00f3","year":"2016","journal-title":"Int. J. Neurorehabilitation."},{"key":"10.1016\/j.conctc.2020.100580_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.eujim.2016.10.004","article-title":"Controlled pilot study for cancer patients suffering from chronic fatigue syndrome due to chemotherapy treated with BioBran (MGN-3-Arabinoxylane) and targeted radiofrequency heat therapy","volume":"8","author":"Petrovics","year":"2016","journal-title":"Eur. J. Integr. Med."},{"key":"10.1016\/j.conctc.2020.100580_bib29","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1038\/s41598-018-20993-y","article-title":"Open-label placebo treatment for cancer-related fatigue: a randomized-controlled clinical trial","volume":"8","author":"Hoenemeyer","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.conctc.2020.100580_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jnci\/95.1.19","article-title":"Placebo effects in oncology","volume":"95","author":"Chvetzoff","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.conctc.2020.100580_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1200\/JCO.2010.28.0107","article-title":"Evidence-based guidelines for determination of sample size and interpretation of the European organisation for the research and treatment of cancer quality of life questionnaire core 30","volume":"29","author":"Cocks","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.conctc.2020.100580_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jclinepi.2012.09.002","article-title":"Sample size calculations for pilot randomized trials: a confidence interval approach","volume":"66","author":"Cocks","year":"2013","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.conctc.2020.100580_bib33","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1177\/0962280215588241","article-title":"Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable","volume":"25","author":"Whitehead","year":"2015","journal-title":"Stat. Methods Med. Res."},{"key":"10.1016\/j.conctc.2020.100580_bib34","series-title":"EORTC QLQ-C30 Scoring Manual","year":"2001"},{"key":"10.1016\/j.conctc.2020.100580_bib35","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41579-018-0029-9","article-title":"Best practices for analysing microbiomes","volume":"16","author":"Knight","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.conctc.2020.100580_bib36","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.conctc.2020.100580_bib37","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.7717\/peerj.1634","article-title":"Estimating and comparing microbial diversity in the presence of sequencing errors","volume":"4","author":"Chiu","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.conctc.2020.100580_bib38","series-title":"Biodivers. Conserv. Phylogenetic Syst. Preserv. Our Evol. Herit. An Extinction Cris.","first-page":"39","article-title":"The PD phylogenetic diversity framework: linking evolutionary history to feature diversity for biodiversity conservation","author":"Faith","year":"2016"},{"key":"10.1016\/j.conctc.2020.100580_bib39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ismej.2010.133","article-title":"UniFrac: an effective distance metric for microbial community comparison","volume":"5","author":"Lozupone","year":"2011","journal-title":"ISME J."},{"key":"10.1016\/j.conctc.2020.100580_bib40","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2014.06.037","article-title":"Conducting a microbiome study","volume":"158","author":"Goodrich","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.conctc.2020.100580_bib41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1890\/12-2010.1","article-title":"PERMANOVA, ANOSIM, and the Mantel test in the face of heterogeneous dispersions: what null hypothesis are you testing?","volume":"83","author":"Anderson","year":"2013","journal-title":"Ecol. Monogr."},{"key":"10.1016\/j.conctc.2020.100580_bib42","article-title":"Analysis of composition of microbiomes: a novel method for studying microbial composition","volume":"26","author":"Mandal","year":"2015","journal-title":"Microb. Ecol. Health Dis."},{"key":"10.1016\/j.conctc.2020.100580_bib43","series-title":"National Health and Medical Research Council, Guidance: Safety Monitoring and Reporting in Clinical Trials Involving Therapeutic Goods","year":"2016"},{"key":"10.1016\/j.conctc.2020.100580_bib44","series-title":"National Statement on Ethical Conduct in Human Research","year":"2007-2018"},{"key":"10.1016\/j.conctc.2020.100580_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/bbrc.1997.8047","article-title":"Anti-HIV activity in vitro of MGN-3, an activated arabinoxylane from rice bran","volume":"243","author":"Ghoneum","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.conctc.2020.100580_bib46","series-title":"BioBran\/MGN-3 (Rice Bran Arab. Coumpound) Basic Clin. Appl. To Integr. Med.","first-page":"9","article-title":"The safety of Biobran\/MGN-3","author":"BioBran Research Foundation","year":"2013"},{"key":"10.1016\/j.conctc.2020.100580_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1758834010395342","article-title":"Health-related quality of life and cancer clinical trials","volume":"3","author":"Osoba","year":"2011","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.conctc.2020.100580_bib48","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/annonc\/mdq721","article-title":"Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations","volume":"22","author":"Luckett","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.conctc.2020.100580_bib49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jclinepi.2013.02.019","article-title":"The Quality of Life Questionnaire Core 30 (QLQ-C30) and Functional Assessment of Cancer-General (FACT-G) differ in responsiveness, relative efficiency, and therefore required sample size","volume":"67","author":"King","year":"2014","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.conctc.2020.100580_bib50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1475-2891-11-27","article-title":"Role of nutritional status in predicting quality of life outcomes in cancer--a systematic review of the epidemiological literature","volume":"11","author":"Lis","year":"2012","journal-title":"Nutr. J."},{"key":"10.1016\/j.conctc.2020.100580_bib51","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5001\/omj.2013.75","article-title":"Quality of life and nutritional status among cancer patients on chemotherapy","volume":"28","author":"Vergara","year":"2013","journal-title":"Oman Med. J."},{"key":"10.1016\/j.conctc.2020.100580_bib52","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1038\/s41598-018-20392-3","article-title":"Being slightly overweight is associated with a better quality of life in breast cancer survivors","volume":"8","author":"Xia","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.conctc.2020.100580_bib53","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/349546","article-title":"Impact of underweight after treatment on prognosis of advanced-stage ovarian cancer","volume":"2014","author":"Kim","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.conctc.2020.100580_bib54","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/jcsm.12206","article-title":"Muscle mass and association to quality of life in non-small cell lung cancer patients","volume":"8","author":"Bye","year":"2017","journal-title":"J. Cachexia. Sarcopenia Muscle."},{"key":"10.1016\/j.conctc.2020.100580_bib55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3892\/mco.2016.964","article-title":"Underweight status predicts a poor prognosis in elderly patients with colorectal cancer","volume":"5","author":"Kaneko","year":"2016","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.conctc.2020.100580_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdv347.04","article-title":"P04 Body mass index (BMI) and quality of life (QoL) in cancer patients \u2013 the \u2018Tor Vergata\u2019 observational study in oNCOlogy\u2013TV-ONCO study","volume":"26","author":"Schirru","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.conctc.2020.100580_bib57","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/jcm8081211","article-title":"Nutrition in cancer patients","volume":"8","author":"Ravasco","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.conctc.2020.100580_bib58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12955-017-0660-6","article-title":"Nutritional status and quality of life of cancer patients needing exclusive chemotherapy: a longitudinal study","volume":"15","author":"Salas","year":"2017","journal-title":"Health Qual. Life Outcome"},{"key":"10.1016\/j.conctc.2020.100580_bib59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/01.NURSE.0000511805.83334.df","article-title":"Using albumin and prealbumin to assess nutritional status","volume":"47","author":"Smith","year":"2017","journal-title":"Nursing (Lond)"},{"key":"10.1016\/j.conctc.2020.100580_bib60","first-page":"188","article-title":"Association between an inflammatory-nutritional index and nutritional status in cancer patients","volume":"28","author":"Pastore","year":"2013","journal-title":"Nutr. Hosp."},{"key":"10.1016\/j.conctc.2020.100580_bib61","first-page":"9","article-title":"Neutrophil-to-lymphocyte ratio and nutritional status in patients with cancer in hospital admission","volume":"15","author":"Leal","year":"2019","journal-title":"Int. J. Canc. Res."},{"key":"10.1016\/j.conctc.2020.100580_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22636","article-title":"Association between neutrophil-to-lymphocyte ratio and nutritional status in geriatric patients","volume":"33","author":"Kaya","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.conctc.2020.100580_bib63","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4213623","article-title":"Prognostic nutritional index and neutrophil-to-lymphocyte ratio are respectively associated with prognosis of gastric cancer with liver metatasis undergoing and without hepatectomy","volume":"2019","author":"Gao","year":"2019","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.conctc.2020.100580_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177620","article-title":"The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer","volume":"12","author":"Paulsen","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.conctc.2020.100580_bib65","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/1097-0142(20010915)92:6+<1684::AID-CNCR1497>3.0.CO;2-Z","article-title":"The role of cytokines in cancer-related fatigue","volume":"92","author":"Kurzrock","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.conctc.2020.100580_bib66","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1634\/theoncologist.12-S1-22","article-title":"Mechanisms of cancer-related fatigue","volume":"12","author":"Ryan","year":"2007","journal-title":"Oncol."},{"key":"10.1016\/j.conctc.2020.100580_bib67","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/039463201402700408","article-title":"MGN-3\/Biobran enhances generation of cytotoxic CD8+ T cells via upregulation of DEC-205 expression on dendritic cells","volume":"27","author":"Ghoneum","year":"2014","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.conctc.2020.100580_bib68","doi-asserted-by":"crossref","first-page":"265","DOI":"10.31989\/ffhd.v2i7.84","article-title":"An open-label, randomized clinical trial to assess the immunomodulatory activity of a novel oligosaccharide compound in healthy adults","volume":"2","author":"Ali","year":"2012","journal-title":"Funct. Foods Health Dis."},{"key":"10.1016\/j.conctc.2020.100580_bib69","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00262-012-1344-z","article-title":"MGN-3 arabinoxylan rice bran modulates innate immunity in multiple myeloma patients","volume":"62","author":"Cholujova","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.conctc.2020.100580_bib70","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.pathol.2016.04.004","article-title":"Comparison of two extractable nuclear antigen testing algorithms: ALBIA versus ELISA\/line immunoassay","volume":"48","author":"Chandratilleke","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.conctc.2020.100580_bib71","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3390\/nu9111237","article-title":"In vitro fermentation patterns of rice bran components by human gut microbiota","volume":"9","author":"Pham","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.conctc.2020.100580_bib72","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1034\/j.1600-0773.2003.920608.x","article-title":"Modified rice bran beneficial for weight loss of mice as a major and acute adverse effect of cisplatin","volume":"92","author":"Endo","year":"2003","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.conctc.2020.100580_bib73","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/10408398.2012.705188","article-title":"Cereal-derived arabinoxylans as biological response modifiers: extraction, molecular features, and immune-stimulating properties","volume":"55","author":"Zhang","year":"2015","journal-title":"Crit. Rev. Food Sci. Nutr."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865420300648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865420300648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:01:30Z","timestamp":1762520490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865420300648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":73,"alternative-id":["S2451865420300648"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2020.100580","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rice bran arabinoxylan compound and quality of life of cancer patients (RBAC-QoL): Study protocol for a randomized pilot feasibility trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2020.100580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100580"}}